Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

Bruker unveils tissue imaging tools for multiplexed spatial proteomics and multiomic imaging

By Brian Buntz | April 11, 2022

Bruker Bruker Corp. (Nasdaq:BRKR) has debuted new technologies for spatial multiomics, single-cell proteomics and cell-line, tissue and plasma proteomics cancer research.

The company announced the new offerings at the American Association for Cancer Research (AACR) Annual Meeting 2022.

Bruker is also building on its strategic investment in AmberGen, a Boston-based life science technology focused on photonic technology. In particular, the companies are exploring new applications of the Ambergen Miralys peptide-code antibody kits used with the Bruker timsTOF flex novel MALDI HiPLEX-IHC workflow for targeted protein expression profiling in tissue.

According to the companies, using the two technologies in tandem can yield highly multiplexed images of target proteins in a wide field of view.

“Spatial protein expression mapping can elucidate processes in immuno-oncology and in TME and metastasis research,” said Dr. Michael L. Easterling, Bruker Director of Imaging Life Sciences Mass Spectrometry, in a press release. “The MALDI HiPLEX IHC workflow based on AmberGen’s peptide-encoded antibody panels provides targeted protein localization and adds the capability to map important lipids, glycan and metabolite markers on the same tissue section.”

Also, at the AACR Annual Meeting, Bruker is displaying the capabilities of the CellScape instrument for high-precision targeted spatial proteomics.


Filed Under: Drug Discovery and Development
Tagged With: AACR, American Association for Cancer Research, Bruker Corp., spatial proteomics
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Lab facility
Massachusetts is competing for ARPA-H biomedical research center
GenScript
GenScript debuts single- and double-strand DNA service for cell and gene therapy development
NIH National Institutes of Health
NIH licenses COVID-19 research technologies to WHO initiative
Janssen
Janssen’s company group chairman dishes on growth strategy

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50